{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:35Z","timestamp":1786988075485,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077091"],"award-info":[{"award-number":["22077091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2026NSFSC0561"],"award-info":[{"award-number":["2026NSFSC0561"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118680","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:16:18Z","timestamp":1771226178000},"page":"118680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of 3-benzyloxy-6-arylpyridazine derivatives as novel multi-target agents toward Parkinson's disease therapy"],"prefix":"10.1016","volume":"307","author":[{"given":"Yichun","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqin","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghuai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6565-6073","authenticated-orcid":false,"given":"Yong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118680_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bastiaan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118680_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2026.118680_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122358","article-title":"Molecular mechanism of cognitive impairment associated with Parkinson's disease: a stroke perspective","volume":"337","author":"Gupta","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2026.118680_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101681","article-title":"Role of platelet in Parkinson's disease: insights into pathophysiology & theranostic solutions","volume":"80","author":"Beura","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2026.118680_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejmech.2026.118680_bib6","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1021\/jm070677y","article-title":"Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs","volume":"50","author":"Binda","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib7","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.2147\/DDDT.S302673","article-title":"The current evidence for the use of safinamide for the treatment of Parkinson's disease","volume":"15","author":"Abbruzzese","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2026.118680_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism","volume":"51","author":"Hauser","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2026.118680_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/srep43703","article-title":"Quantifying Fenton reaction pathways driven by self-generated H2O2 on pyrite surfaces","volume":"7","author":"Gil-Lozano","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118680_bib10","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1046\/j.1471-4159.1998.71052112.x","article-title":"Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species","volume":"71","author":"Spencer","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2026.118680_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mds.27947","article-title":"Meta-analysis of copper and iron in Parkinson's disease brain and biofluids","volume":"35","author":"Genoud","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejmech.2026.118680_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118680_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1306.017","article-title":"The relevance of iron in the pathogenesis of Parkinson's disease","volume":"1012","author":"Goetz","year":"2004","journal-title":"Ann. NY. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.118680_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00702-010-0531-3","article-title":"Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration","volume":"118","author":"Dexter","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2026.118680_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in Parkinson's disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2026.118680_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118680_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1434512","article-title":"The relation between Parkinson's disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis","volume":"15","author":"Badawoud","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118680_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117453","article-title":"Research progress and perspectives of dual-target inhibitors","volume":"289","author":"Pang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib19","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.2174\/092986712800672139","article-title":"Some recent approaches of biologically active substituted pyridazine and phthalazine drugs","volume":"19","author":"Asif","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejmech.2016.07.061","article-title":"The therapeutic journey of pyridazinone","volume":"123","author":"Akhtar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4155\/fmc-2016-0194","article-title":"Pyridazinone: an attractive lead for anti-inflammatory and analgesic drug discovery","volume":"9","author":"Singh","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s43440-020-00070-w","article-title":"Synthesis, molecular modeling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors","volume":"72","author":"Ozdemir","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2026.118680_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104203","article-title":"Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy","volume":"104","author":"Rodr\u00edguez-Enr\u00edquez","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/0118715273340983241018095529","article-title":"Parkinson's disease: unravelling the medicinal perspectives and recent developments of heterocyclic monoamine oxidase-B inhibitors","volume":"24","author":"Rana","year":"2025","journal-title":"Cns Neurol Disord-Dr"},{"key":"10.1016\/j.ejmech.2026.118680_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2019.03.009","article-title":"Clioquinol: to harm or heal","volume":"199","author":"Perez","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.118680_bib26","first-page":"1","article-title":"Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases","volume":"10","author":"Chen","year":"2025","journal-title":"Int. J. Software Tool. Technol. Tran."},{"key":"10.1016\/j.ejmech.2026.118680_bib27","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1007\/s12035-022-02974-5","article-title":"The zinc ionophore clioquinol reduces Parkinson's disease patient-derived brain extracts-induced neurodegeneration","volume":"59","author":"Teil","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2026.118680_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acschemneuro.5b00253","article-title":"Clioquinol improves cognitive, motor function, and microanatomy of the alpha-synuclein hA53T transgenic mice","volume":"7","author":"Finkelstein","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118680_bib29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-1993-25861","article-title":"One-pot synthesis of 6-substituted 3(2H)-pyridazinones from ketones","volume":"3","author":"Coates","year":"1993","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2026.118680_bib30","series-title":"Process for Preparing 3-chloro-6-(2-hydroxyphenyl)-pyridazines","author":"Bing","year":"1982"},{"key":"10.1016\/j.ejmech.2026.118680_bib31","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1002\/anie.200461286","article-title":"New, readily available biaryl P, N-ligands for asymmetric catalysis","volume":"43","author":"Kn\u00f6pfel","year":"2004","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118680_bib32","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.bmcl.2015.02.002","article-title":"Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors","volume":"25","author":"Dorsch","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118680_bib33","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1021\/jm001088u","article-title":"Design, synthesis, and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino] pyridazine derivatives as acetylcholinesterase inhibitors","volume":"44","author":"Contreras","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib34","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1021\/acsomega.0c00045","article-title":"Expeditious green synthesis of novel 4-methyl-1,2,5,6-tetraazafluoranthen-3(2H)-one analogue from ninhydrin: N\/S alkylation and Aza-Michael addition","volume":"5","author":"Boraei","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.118680_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ejmech.2015.12.015","article-title":"Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives","volume":"108","author":"George","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bioorg.2019.03.043","article-title":"Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease","volume":"87","author":"Zhang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib37","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1021\/jf900882c","article-title":"Design, synthesis, and bioactivity study of novel benzoylpyridazyl ureas","volume":"57","author":"Sun","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib38","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1016\/S0040-4039(98)01230-1","article-title":"Organic reaction in water. Part 2. A new method for dechlorination of chlorobiphenyls using a raney Ni-Al alloy in dilute aqueous alkaline solution","volume":"39","author":"Liu","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2026.118680_bib39","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1021\/jo00364a002","article-title":"Coupling of aryl chlorides by Nickel and reducing metals","volume":"51","author":"Colon","year":"1986","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104895","article-title":"Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer\u2019s disease agents","volume":"111","author":"Ye","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib41","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1021\/acs.jmedchem.4c02659","article-title":"Network-based drug optimization toward the treatment of Parkinson's disease: NRF2, MAO-B, oxidative stress, and chronic neuroinflammation","volume":"68","author":"Duarte P","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bmcl.2018.01.049","article-title":"Selective inhibition of monoamine oxidase a by hispidol","volume":"28","author":"Baek","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118680_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2014.02.010","article-title":"Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release","volume":"143","author":"Finberg","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.118680_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/jf0305231","article-title":"Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay","volume":"52","author":"D\u00e1valos","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114098","article-title":"Development of novel 2-aminoalkyl-6-(2-hydroxyphenyl)pyridazin-3(2H)-one derivatives as balanced multifunctional agents against Alzheimer's disease","volume":"230","author":"Shi","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib46","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.4103\/NRR.NRR-D-24-00642","article-title":"Copper homeostasis and neurodegenerative diseases","volume":"20","author":"Wang","year":"2025","journal-title":"Neural Regener. Res."},{"key":"10.1016\/j.ejmech.2026.118680_bib47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2008.09.001","article-title":"Oxidative stress hypothesis in Alzheimer's disease: a reappraisal","volume":"29","author":"Pratico","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.118680_bib48","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1021\/acs.jmedchem.6b00636","article-title":"Development of multifunctional pyrimidinylthiourea derivatives as potential anti-Alzheimer agents","volume":"59","author":"Li","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105623","article-title":"6-Benzyloxyphthalides as selective and reversible monoamine oxidase B inhibitors with antioxidant and anti-neuroinflammatory activities for Parkinson's disease treatment","volume":"120","author":"Song","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib51","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib52","article-title":"Human urinary kallidinogenase reduces lipopolysaccharide-induced neuroinflammation and oxidative stress in BV-2 Cells, Pain Res","volume":"2019","author":"Zhao","year":"2019","journal-title":"Manag."},{"key":"10.1016\/j.ejmech.2026.118680_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention","volume":"304","author":"Liu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2026.118680_bib54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000369933","article-title":"Role of immunity and inflammation in the pathophysiology of neurodegenerative diseases","volume":"15","author":"Fakhoury","year":"2015","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.ejmech.2026.118680_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116099","article-title":"Synthesis and evaluation of butylphthalide-scutellarein hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"265","author":"Yu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1021\/acschemneuro.4c00679","article-title":"Brazilin-rich extract from Caesalpinia sappan L. attenuated the motor deficits and neurodegeneration in MPTP\/p-induced Parkinson's disease mice by regulating gut microbiota and inhibiting inflammatory responses","volume":"16","author":"Gao","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118680_bib57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1021\/acschemneuro.7b00247","article-title":"Gastrodin and isorhynchophylline synergistically inhibit MPP+-induced oxidative stress in SH-SY5Y cells by targeting ERK1\/2 and GSK-3\u03b2 pathways: involvement of Nrf2 nuclear translocation","volume":"9","author":"Li","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118680_bib58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0968-0896(97)10048-7","article-title":"New orally active enkephalinase inhibitors: their synthesis, biological activity, and analgesic properties","volume":"6","author":"Senokuchi","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118680_bib59","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2026.118680_bib60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.etp.2011.01.013","article-title":"1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenyl piridinium (MPP+) converted from MPTP through MAO-B","volume":"64","author":"Corsini","year":"2012","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.ejmech.2026.118680_bib61","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1523\/JNEUROSCI.22-11-04639.2002","article-title":"Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease","volume":"22","author":"Goldberg","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118680_bib62","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.12659\/MSM.908021","article-title":"Astragalus polysaccharide protects neurons and stabilizes mitochondrial in a mouse model of Parkinson disease","volume":"24","author":"Liu","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejmech.2026.118680_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neulet.2013.02.066","article-title":"The effect of dopamine on MPTP-induced rotarod disability","volume":"543","author":"Ayton","year":"2013","journal-title":"Neurosci. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:11:44Z","timestamp":1777529504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":63,"alternative-id":["S022352342600125X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118680","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 3-benzyloxy-6-arylpyridazine derivatives as novel multi-target agents toward Parkinson's disease therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118680"}}